Mitigating the Risks of Generic Drug Product Development: An Application of Quality by Design (QbD) and Question based Review (QbR) Approaches
AbstractThis paper discusses the challenges and opportunities of implementing the Quality by Design (QbD) and Question based Review (QbR) approaches in developing solid dosage formulations and manufacturing processes for generic drug products. Formulation and process development of a drug product is a challenge due to the inherent variability associated with the activity. Regulatory bodies, such as the Food and Drug Administration (FDA) of the USA, require the QbD approach in developing formulations and processes for drug products. The QbD approach is described in the International Conference on Harmonisation (ICH) guidance Q8 (R2). The regulatory reviewers follow the QbR approach during the review of Chemistry, Manufacturing, and Controls (CMC), which have also adopted some of the elements of the QbD guidance. A systematic application of scientific principles in developing the formulations and processes for generic drug products following the QbD approach is outlined in three main categories. The categories are (A) product understanding, (B) process understanding, and (C) control strategy. The concept of predefined objectives, quality risk management, and CMC considerations along with the prior knowledge are discussed in details. The discussions and explanations provided in this paper are based on sound scientific principles as well as practical experience and approaches applied to resolve product quality and manufacturing issues. Emphasis is given to streamlining the formulations and process development activity to comply with the QbD and QbR principles and to avoid commonly cited deficiencies. The examples are provided as guiding tools for the generic formulation and process development professionals.
How to Cite
KADER, Manjurul. Mitigating the Risks of Generic Drug Product Development: An Application of Quality by Design (QbD) and Question based Review (QbR) Approaches. Journal of Excipients and Food Chemicals, [S.l.], v. 7, n. 2, p. 35-75, july 2016. ISSN 21502668. Available at: <https://ojs.abo.fi/ojs/index.php/jefc/article/view/1420>. Date accessed: 27 nov. 2022.
Generic Formulation Development, Quality by Design (QbD), Quality based Review (QbR), Product and Process Understanding, Chemistry Manufacturing and Controls (CMC).
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).